Monitoring the action of redox-directed cancer therapeutics using a human peroxiredoxin-2-based probe

Current sensors for intracellular H2O2 are not sensitive enough to detect all biologically relevant H2O2 fluctuations. Here the authors develop a peroxiredoxin-2-based FRET probe that is sensitive enough to measure changes in H2O2 concentration in response to the cancer therapeutic piperlongumine.

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Troy F. Langford, Beijing K. Huang, Joseph B. Lim, Sun Jin Moon, Hadley D. Sikes
Format: article
Langue:EN
Publié: Nature Portfolio 2018
Sujets:
Q
Accès en ligne:https://doaj.org/article/1ada60e3af9c4daab6f468fb7f0175c1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!